Table 4. Pharmacokinetic parameters of tacrolimus from self-microemulsifying gastricretentive sustained release tablets and commerical capsules.
No | Order of administration | AUC(0–t) (ng·h·mL−1) |
AUC(0–∞) (ng·h·mL−1) |
tmax(h) |
Cmax (ng·mL−1) |
F% | ||||
---|---|---|---|---|---|---|---|---|---|---|
SEGTa | CCb | SEGT | CC | SEGT | CC | SEGT | CC | |||
1 | SMEGSRT/CC | 88.20 | 28.54 | 126.22 | 40.56 | 4 | 1 | 6.61 | 4.82 | 309.0 |
2 | SMEGSRT/CC | 206.91 | 18.67 | 252.52 | 25.68 | 8 | 1 | 11.54 | 2.50 | 1107.8 |
3 | SMEGSRT/CC | 74.48 | 43.99 | 85.39 | 68.74 | 6 | 1 | 6.02 | 5.01 | 169.3 |
4 | CC/SMEGSRT | 209.91 | 32.11 | 320.47 | 48.21 | 10 | 1 | 11.23 | 3.98 | 653.7 |
5 | CC/SMEGSRT | 82.73 | 26.21 | 103.03 | 35.65 | 4 | 1 | 7.80 | 3.47 | 315.6 |
6 | CC/SMEGSRT | 194.35 | 25.41 | 265.86 | 33.14 | 8 | 1 | 9.96 | 2.88 | 764.9 |
Mean | 142.76 | 29.16 | 192.25 | 42.00 | 6.67 | 1 | 8.86 | 3.78 | 553.4 | |
SD | 67.12 | 8.51 | 99.23 | 15.10 | 2.42 | 0 | 2.38 | 1.02 | 353.8 |
aSMEGSRT self-microemulsifying gastricretentive sustained release tablets.
bCC commercial capsules.